NEW YORK (GenomeWeb News) – Thermo Fisher Scientific first contacted Life Technologies about a possible merger more than a year-and-a-half ago with a proposed deal at $58 per share, Life Technologies said in a proxy statement filed on Tuesday.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.
Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.
MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.
Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.